Florence Chaverneff, PhD

Treatment with lofexidine may provide better control of the symptoms of opioid withdrawal syndrome compared with placebo.

Discontinuing short- or long-term use of esketamine nasal spray for treatment-resistant depression may not be associated with withdrawal symptoms.

Experts discuss how differentiation between the PTSD and TBI is important for the purposes of disability evaluation and treatment.

Virtual reality technology may be useful in such areas as exposure therapy and pain management.

The implementation of a standardized medication regimen for pain management in incoming psychiatric inpatients may be associated with a reduction in the number of pages related to pain complaints received by on-call residents.

The American Psychiatric Association’s president, Altha Stewart, MD, sat with Valerie Jarrett, JD, for a fireside chat focused on the Affordable Care Act.

A series of 3 articles published in the Lancet is dedicated to highlighting the nature of current postsurgical pain management practices, including the use of peri- and postoperative opioids, that are thought to play a part in driving the opioid crisis.

The Stopping the Transmission of Opioids to the Next Generation tool allows clinicians treating women of childbearing age with opioid use disorder to estimate risks associated with pregnancies in this patient population.

Dr Cosio presented results from a preliminary study examining the prevalence of mental health disorders in veterans with chronic pain.

The prevalence of opioid use disorder rose in women delivering at hospitals across 28 US states and the District of Columbia between 1999 and 2014, with quadrupling at the national level during this period.

Causes of death in the year after a nonfatal opioid overdose were often related to substance use disorders, as well as to a range of mental health and medical conditions.

Few of the individuals who experience an opioid-related overdose had received treatment for opioid use disorder.

The US Food and Drug Administration has issued warnings to 3 companies selling kratom-containing products with unsubstantiated claims regarding their effectiveness in conditions that include opioid withdrawal and addiction and chronic pain.

April 28, 2018 is National Prescription Drug Take Back Day.

Katie Burk, MPH, presented measures undertaken by the city of San Francisco to provide integrated responses to the concurrent HIV/HCV and opioid public health epidemics.

Package inserts of opioid analgesics may not consistently provide information regarding safe drug storage and/or disposal.

Synthetic cannabinoid use may result in shorter hospital stays and reduced antipsychotic doses in patients with bipolar disorder.

Ketamine may represent an effective adjunct for the treatment of suicidal ideation in patients with major depressive disorder.

Delayed sleep-wake phase disorder may be a predictor of relapse in euthymic patients with bipolar disorder.

The FDA has announced the approval of Sublocade for the treatment of moderate to severe opioid use disorder.

The opioid crisis needs to be addressed in order to reduce overdose deaths.

Should the statistical significance of the P-value be lowered?

Elderly patients have a higher prevalence of chronic pain than younger adults.

Increases in autonomic function may predict the occurrence and severity of auditory hallucinations in patients with schizophrenia, suggesting a regulation of these experiences by the autonomic nervous system.

Long-term abstinence after cocaine dependence was shown to be associated with improved sleep quality after an initial worsening period.

Quetiapine-XR may be effective in reducing substance abuse in patients with bipolar disorder.

Vestibular rehabilitation was found to ameliorate headache, dizziness, and psychological factors in patients with vestibular migraine or a combination of tension-type headache and dizziness.

Posttraumatic stress disorder severity may be related to chronic headache pain.

Post-surgery pain is a continuum with no clear delineation.

The opioid crisis in Pennsylvania has led to voluntary guidelines emphasizing medication-assisted treatment.